跳至主要内容
临床试验/CTRI/2025/07/090590
CTRI/2025/07/090590尚未招募2 期

Randomised Comparative Three Arm clinical study to evaluate the efficacy of Khadiradi Kashay orally, Khadiradi Raskriya Topically and Both combined together in Ekakushtha wsr to Psoriasis

Dr Rushikesh Patil1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年7月25日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
1. To study the efficacy of khadiradi Raskriya topically

研究概览

简要总结

Certainly exploring various treatment modalities for Ekakushta (psoriasis) is crucial especially considering its tendency for relapse in many patients Research into different approaches can lead to better management and potentially more effective long-term outcomes Ayurveda offers a holistic approach to treating psoriasis focusing on balancing the bodys energies and promoting overall wellbeing Many people find relief and long-term benefits from Ayurvedic treatments for psoriasis In modern medicine there is only antifungal and steroid treatment PUVA therapy which gives serious side effects like hepatic nephrotoxixity  bone marrow depression,but recurrence is very common Hence its is the need to find out safe and effective treatment for psoriasis and here ayurveda plays an importance role treatment modality of ayuveda provided long lasting results and better life to patient  Skin is very essential organ for cosmetic purpose Person look is the main factor of the personality In the patient of psoriasis the mental health of the mind is disturbed due to his look So for the cosmetic purpose I selected khadiradi rasakriya for topically use which is easily available and affordable for patients So we have decided to study

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)

入选标准

  • Age group:.
  • 18 to 60 years. 2) Patients with clinical features of EKA-KUSHTA having signs and symptoms namely Kandu (itching), Shushkta, Vaivarnya (Depigmentation),Mastyashakloptama (silvery patchy skin). 3) Patients of both Gender. 13 4) Patient who is willing to participate and in written provide in inform consent will be entertain in study.

排除标准

  • Patient suffering from any chronic skin disease, immune suppressed systemic disorders.
  • Patient suffering from any other systemic disorders like tuberculosis, diabetes melitus, HBsAg positive patients and known case of leprosy.
  • Pregnant & Lactating woman.
  • Psoriatic arthritis.

结局指标

主要结局

1. To study the efficacy of khadiradi Raskriya topically

时间窗: 9 weeks

using PASI score in ekakustha. ( psoriasis )

时间窗: 9 weeks

2. To study the efficacy of khadiradi kashaya orally using PASI

时间窗: 9 weeks

score in ekakustha. . ( psoriasis )

时间窗: 9 weeks

次要结局

  • To compare the effect of khadiradi Raskriya topically with khadiradi(kashaya orally in signs & symptoms of ekakustha.)

研究者

发起方
Dr Rushikesh Patil
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Rushikesh Patil

Aarogyashala Rugnalaya

研究点 (1)

Loading locations...

相似试验